50% off Premium Yearly
Too speculative. They lose money.
Stock price when the opinion was issued
As of Oct 12, 2026. Market Open.
Up 152% last year. They got FDA approval for one of their top drugs last year to treat a lung condition. It pulled back 18% last month due to a disappointing trial result in a drug. Worth watching this.
Build your watch list
Sign in to track investmentsyou care about
at Raymond James Investment Counsel Ltd.
Lightwater Partners
Stockchase Premium
CNBC
First Avenue Investment Counsel
Too speculative. They lose money.